All Pharma News
Very successful capital increase for NFL Biosciences with over €3 million raised

Very successful capital increase for NFL Biosciences with over €3 million raised
GLOBENEWSWIRE
31 Jan 2023
Share Share
NFL Biosciences: 2022 first-half business and earnings

NFL Biosciences: 2022 first-half business and earnings
GLOBENEWSWIRE
25 Oct 2022
Share Share
Inauguration of new R&D facility in Mumbai, India by Mr. Jean-Marc Séré-Charlet, Consul General of France- Mumbai

Inauguration of new R&D facility in Mumbai, India by Mr. Jean-Marc Séré-Charlet, Consul General of France- Mumbai
PRESS RELEASE
30 Sep 2022
Share Share
Athena’s First Market Authorization in Brazil with Ondansetron ODT

Athena’s First Market Authorization in Brazil with Ondansetron ODT
PRESS RELEASE
22 Mar 2022
Share Share
NFL BIOSCIENCES: co-development agreement for a drug candidate

NFL BIOSCIENCES: co-development agreement for a drug candidate
GLOBENEWSWIRE
02 Feb 2022
Share Share
Athena steps up its R&D output in France and India

Athena steps up its R&D output in France and India
PRESS RELEASE
18 Nov 2021
Share Share
The call for help from generic drug manufacturers

The call for help from generic drug manufacturers
Keren Lentschner LEFIGARO
12 Oct 2021
Share Share
Athena Pharmaceutiques acquires Bisoprolol + Aspirin Capsules Dossier and Patent

Athena Pharmaceutiques acquires Bisoprolol + Aspirin Capsules Dossier and Patent
PRESS RELEASE
07 Oct 2021
Share Share
Athena Inpharmasci approved by Korean and Taiwan GMP following

Athena Inpharmasci approved by Korean and Taiwan GMP following
PRESS RELEASE
10 Feb 2021
Share Share
ATHENA’s First Launch in Russia with Levocetirizine ODT

ATHENA’s First Launch in Russia with Levocetirizine ODT
PRESS RELEASE
16 Oct 2020
Share Share